NPPA asks drug firms to cut prices in wake of GST rate reduction

| | New Delhi
  • 0

NPPA asks drug firms to cut prices in wake of GST rate reduction

Thursday, 17 June 2021 | PTI | New Delhi

Drug pricing regulator NPPA has asked pharmaceutical companies and medical device makers to reduce prices on products on which the GST has been lowered in order to pass on the benefit to the consumers. In a notification, the National Pharmaceutical Pricing Authority (NPPA) noted that a change in tax rates has an impact on the fixation of maximum retail prices (MRP) of various drugs and formulations.

As per DPCO 2013, MRP of drugs and formulations are inclusive of taxes. Therefore, any downward change in tax or GST rates should be reflected in the MRP and benefit of the reduction should be passed on to the consumers, it noted.

“In view of the above, all the manufacturers and marketing companies are required to revise the MRPs of drugs/formulations on which tax/GST rates have been reduced taking into effect the revised GST rates,” NPPA said.

Recalling or re-labelling or re-stickering on the label of the container or pack of the already released stocks in the market is not mandatory if manufacturers are able to ensure price compliance at the retailer level through issuance of a revised price list, it noted.

Sunday Edition

Pandemic: A Triple-Whammy for Parents

26 September 2021 | RamG Vallath | Agenda

Attached to none

26 September 2021 | Hingori | Agenda

Turn to art for progress

26 September 2021 | Aarrti Zaveri | Agenda

God is easily pleased

26 September 2021 | Ajit Kumar Bishnoi | Agenda

Astroturf : Living in demanding mode

26 September 2021 | Bharat Bhushan Padmadeo | Agenda

Meet India’s young writers

26 September 2021 | Shalini Saksena | Sunday Pioneer